Pacemakers Market By Product (Implantable : (Single Chamber, Dual Chamber, Biventricular) and External) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Failure to restore normal sinus rhythm of the heart results in abnormal or ectopic heartbeat, often referred as cardiac arrhythmia. The arrhythmia is initiated by three discernable etiologies such as re-entry, automaticity and triggered. Automaticity occurs due to alterations in the ion exchange at cellular level. Re-entry occurs when the propagating electric impulse does not fade away and re-excites the heart even after the refractory period is over. Triggered events rarely occur from abnormalities encountered in the heart muscles ion exchange. Pacemakers are used in patients to maintain the normal heartbeat in patients suffering with cardiac arrhythmias.

Pacemakers used for the treatment of irregular heartbeats are segmented as implantable and external. The implantable pacemakers are further categorized as single chamber, dual chamber and biventricular pacemakers. There is tremendous demand for dual chamber pacemakers due to their dual ability to stimulate the right atrium and right ventricle. Biventricular pacemakers are also referred as cardiac resynchronization therapy (CRT) serves as a lucrative market in the near future.

The geography segment for the pacemakers market consists of five major regional segments along with their major countries which are as follows:

• North America
  
  • U.S.
  • Canada
• Europe
  
  • U.K.
  • Germany
  • Rest of Europe
• Asia Pacific
  
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Latin America
  
  • Mexico
  • Brazil
  • Rest of LATAM
• Middle East and Africa
  
  • GCC
  • Rest of Middle East and Africa
  •  

Country cross-sectional analysis regarding different types of pacemakers available is done by giving the data forecast and market estimation.

Porter’s five forces model gives a brief idea regarding the competitive rivalry in the pacemakers market. Market assessment provides comprehensive information about the existing business milieu in the pacemakers market. Key developments section in the company profiles tracks all the recent mergers, acquisitions and strategic partnerships between medical device manufacturers to upgrade the technical aspects related to cardiac pacemakers. Product portfolio exhibits the various pacemakers offered by major market players which include Boston Scientific Corporation, Biotronik, Inc., Cordis, Inc., Medtronic Plc, MEDICO S.p.A., OSCOR, Inc., Pacetronix, St. Jude Medical, Vitatron and ZOLL Medical Corporation.

For the purpose of this study, the global pacemakers market is categorized into the following regional and country specific markets:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC
  • Rest of Middle East and Africa

The Centers for Disease Control and Prevention 2015 report has cited that in the United States approximately 2.7 to 6.1 million people are suffering with atrial fibrillation. Around 2% of the people below 65 years of age and 9% people above 65 years of age have atrial fibrillation. The occurrence is more in people having European descent and less likely to occur in African American individuals. Rising public health awareness and increasing number of patients being diagnosed with cardiac arrhythmia drive the pacemakers market in North America. 

Technological advancement in the development of pacemakers in Western Europe and rising prevalence of cardiac complications in Eastern Europe drive the pacemakers market in Europe. Asia Pacific will be the most potential regional market during the forecast period from 2018 to 2026 owing to the growing penetration of major medical device companies manufacturing cardiac pacemakers. The affordable reimbursement scenario for cardiac pacemakers also contributes to the market growth of Asia Pacific.